레바미피드의 용해도가 향상된 사원 고체분산체 시스템

The objective of this study was to prepare and evaluate microcapsules based on quaternary solid dispersions containing rebamipide to enhance solubility and dissolution rates. After screening numerous pH modifiers, polymers, and surfactants, L-arginine, gelatin, and SLS were selected as the alkalizer...

Full description

Saved in:
Bibliographic Details
Published inYaghag-hoi-ji Vol. 68; no. 4; pp. 215 - 222
Main Authors 조대영(Dae Yeong Cho), 김문정(Moon Jung Kim), 김경수(Kyeong Soo Kim)
Format Journal Article
LanguageKorean
Published The Pharmaceutical Society Of Korea 31.08.2024
대한약학회
Subjects
Online AccessGet full text
ISSN0377-9556
2383-9457
DOI10.17480/psk.2024.68.4.215

Cover

Abstract The objective of this study was to prepare and evaluate microcapsules based on quaternary solid dispersions containing rebamipide to enhance solubility and dissolution rates. After screening numerous pH modifiers, polymers, and surfactants, L-arginine, gelatin, and SLS were selected as the alkalizer, soluble polymer, and surfactant, respectively. Various microcapsules were prepared through a spray-drying process, and their physicochemical properties, solubility, and dissolution profiles were investigated. The microcapsules containing rebamipide, L-arginine, gelatin, and SLS in a weight ratio of 1:1:0.5:1 provided an amorphous drug form and a spherical particle shape. They exhibited excellent solubility and dissolution rates compared to pure rebamipide powder. Additionally, the microcapsules were evaluated against commercial tablets and showed superior dissolution rates in both water and a pH 4.0 buffer compared to the rebamipide powder and the tablets. Furthermore, they enhanced stability by reducing the recrystallization rate of rebamipide, which tends to recrystallize quickly at low pH. Consequently, we successfully prepared microcapsules based on quaternary solid dispersions of rebamipide to enhance solubility and dissolution rates. These microcapsules could be utilized in formulation development studies to improve the bioavailability of poorly soluble rebamipide. KCI Citation Count: 0
AbstractList The objective of this study was to prepare and evaluate microcapsules based on quaternary solid dispersions containing rebamipide to enhance solubility and dissolution rates. After screening numerous pH modifiers, polymers, and surfactants, L-arginine, gelatin, and SLS were selected as the alkalizer, soluble polymer, and surfactant, respectively. Various microcapsules were prepared through a spray-drying process, and their physicochemical properties, solubility, and dissolution profiles were investigated. The microcapsules containing rebamipide, L-arginine, gelatin, and SLS in a weight ratio of 1:1:0.5:1 provided an amorphous drug form and a spherical particle shape. They exhibited excellent solubility and dissolution rates compared to pure rebamipide powder. Additionally, the microcapsules were evaluated against commercial tablets and showed superior dissolution rates in both water and a pH 4.0 buffer compared to the rebamipide powder and the tablets. Furthermore, they enhanced stability by reducing the recrystallization rate of rebamipide, which tends to recrystallize quickly at low pH. Consequently, we successfully prepared microcapsules based on quaternary solid dispersions of rebamipide to enhance solubility and dissolution rates. These microcapsules could be utilized in formulation development studies to improve the bioavailability of poorly soluble rebamipide. KCI Citation Count: 0
Author 김문정(Moon Jung Kim)
김경수(Kyeong Soo Kim)
조대영(Dae Yeong Cho)
Author_xml – sequence: 1
  fullname: 조대영(Dae Yeong Cho)
– sequence: 2
  fullname: 김문정(Moon Jung Kim)
– sequence: 3
  fullname: 김경수(Kyeong Soo Kim)
BackLink https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003118580$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNotkD1Lw0AAhg-pYK39A05ZXITEy33lMpbiR6UgSPeQXO6kRBJpXNy0Vig6WLCKaIQOOgiCRYs4-Iuay3-wWKfnHR6e4V0GpTiJJQCrNrRsh3C4cZRGFoKIWIxbxEI2XQBlhDk2XUKdEihD7DimSylbAtU0bQcQM-RwB9My2M1H_Xw8zN-_i-FPfpPpp3tDP7wWt5P8ujcdnxrF3Ys-P8sHmaG7b_pxYEw_R_pjkn_1dHc8G4a-yvTlc3GRrYBF5R-msvrPCmhtbbbqO2Zzb7tRrzXNiFFqYuErFXCfkxATQmnousJVWHDFFSIIS-FjHvg8kMIOA-krImFIIUKEYcalwBWwPs_GHeVFou0lfvuPB4kXdbzafqvh2ZDNnmF0Jq_N5egkCRIvSJJIyPhYdjwCbQiZyxHitot_Aa14d2E
ContentType Journal Article
Copyright COPYRIGHT(C) KYOBO BOOK CENTRE ALL RIGHTS RESERVED
Copyright_xml – notice: COPYRIGHT(C) KYOBO BOOK CENTRE ALL RIGHTS RESERVED
DBID P5Y
SSSTE
ACYCR
DOI 10.17480/psk.2024.68.4.215
DatabaseName Scholar (EKS)
Scholar(스콜라)
Korean Citation Index
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Quaternary Solid Dispersion System containing Rebamipide with Enhanced Solubility
EISSN 2383-9457
EndPage 222
ExternalDocumentID oai_kci_go_kr_ARTI_10617465
4010069822819
GroupedDBID 123
9ZL
ALMA_UNASSIGNED_HOLDINGS
P2P
P5Y
SSSTE
ACYCR
ID FETCH-LOGICAL-k655-3caffb8a84d34455d99c9f3c8f8f2423eca38ba8bec1dbeaf4e0d502246368ec3
ISSN 0377-9556
IngestDate Fri Sep 27 04:43:39 EDT 2024
Tue Feb 18 15:18:46 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Spray drying
Solid dispersion
Rebamipide
Dissolution
Microcapsule
Solubility
Language Korean
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-k655-3caffb8a84d34455d99c9f3c8f8f2423eca38ba8bec1dbeaf4e0d502246368ec3
PageCount 8
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_10617465
kyobo_bookcenter_4010069822819
PublicationCentury 2000
PublicationDate 2024-08-31
PublicationDateYYYYMMDD 2024-08-31
PublicationDate_xml – month: 08
  year: 2024
  text: 2024-08-31
  day: 31
PublicationDecade 2020
PublicationTitle Yaghag-hoi-ji
PublicationYear 2024
Publisher The Pharmaceutical Society Of Korea
대한약학회
Publisher_xml – name: 대한약학회
– name: The Pharmaceutical Society Of Korea
SSID ssib036278735
ssj0000615188
ssib051116396
ssib044765145
ssib001106857
Score 2.2649324
Snippet The objective of this study was to prepare and evaluate microcapsules based on quaternary solid dispersions containing rebamipide to enhance solubility and...
SourceID nrf
kyobo
SourceType Open Website
Publisher
StartPage 215
SubjectTerms 약학
TableOfContents 서 론(Introduction) 방 법(Methods) 결과 및 고찰(Results and Discussion) 결 론(Conclusion) 감사의 말씀(Acknowledgment) Conflict of Interest References
Title 레바미피드의 용해도가 향상된 사원 고체분산체 시스템
URI https://scholar.kyobobook.co.kr/article/detail/4010069822819
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003118580
Volume 68
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 약 학 회 지, 2024, 68(4), , pp.215-222
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9RAFA-1XryIn1g_SkDTyzbrJpnJTo5J2lJbqgVXaE9LPibdutDItj2sB9FaQfRgwSqiK_SgB0GwaBEP_kVN9n_wvdlsk6UFq5fs7MvMm1_mzcd78_FGkm54VdzaSnxVY1xXScgt1dcqvhpEPKK-GVIa4tTA3G1z-h6ZWaALQydoYdfS-ppfDh4eea7kf6QKNJArnpL9B8keMAUChEG-8AQJw_NYMlYmHcWuKIxhwKkoFhGUKcUBygT-dVykWIZiQcBVLCCykgjZim2JSFRxRDI2pTAI2MiIVUrinanYFGMzAzROwQkycQUDpit2jydSSyKhgWiA5OgZT8cUPEVsJ3_VY-BkoBhAIZgdo0ApasuL3lLDW1Ib8bJ6f7lfNTCJrQl2ANrFrRqIgiFCnU14vLTI8QIltxEXpjkEPktEdhA4lpCLcOH7dTYXQyOYgX6vJG6XPiqVLaBPCMAMs9PZbFtkdDeOi8myKRSd9OeEs0qPDXK-MbCC0N8yeycqzcagvRd6ZUOsefe8ofeHEJMVmgoZGA9oQbXQe0ewD41aVSL2eT5YbZYRXtlkZVI-SDrgDRzMYXQuDWodQ2e3J_VqVexOmHs0mWvBYOazfDEbVBTolXOtmJCqSQuLyaByg1KeeV3sKTAauukT62_Zx2bHzRDozUMwwa5rtmM_BvVspRUV1LPaGel0ZlfJdq-RnJWGmvE5aSwr7_a4XMvPGa6Oy2PyfO6yvX1emkl2nie728m3X93t38nrTvrxnZy-_9J9s5e82tzffSx3335Onz5JtjpyuvE1_bAl7__YSb_vJT83041dCMjpy0764lP3WeeCVJuarLnTanbLiNo0KVWNwIsin3mMhAYh0DVZVmBFRsAiFqGtwQPPYL7HoK_TQp97EeGVkAo_jIbJeGBclIZX4hV-SZJhLNP8SJyMAjsoIIyHFY8H1OJaYIV6MCKNinKqo_2Me695qz4gzxHpOhRgvRks19HrO_4uxfVmqw627a06Tt5UiUkv_43NFelUXsuvSsNrrXV-DVTnNX9UVJQ_sp2pBA
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%EB%A0%88%EB%B0%94%EB%AF%B8%ED%94%BC%EB%93%9C%EC%9D%98+%EC%9A%A9%ED%95%B4%EB%8F%84%EA%B0%80+%ED%96%A5%EC%83%81%EB%90%9C+%EC%82%AC%EC%9B%90+%EA%B3%A0%EC%B2%B4%EB%B6%84%EC%82%B0%EC%B2%B4+%EC%8B%9C%EC%8A%A4%ED%85%9C&rft.jtitle=Yaghag-hoi-ji&rft.au=%EC%A1%B0%EB%8C%80%EC%98%81%28Dae+Yeong+Cho%29&rft.au=%EA%B9%80%EB%AC%B8%EC%A0%95%28Moon+Jung+Kim%29&rft.au=%EA%B9%80%EA%B2%BD%EC%88%98%28Kyeong+Soo+Kim%29&rft.date=2024-08-31&rft.pub=The+Pharmaceutical+Society+Of+Korea&rft.issn=0377-9556&rft.volume=68&rft.issue=4&rft.spage=215&rft.epage=222&rft_id=info:doi/10.17480%2Fpsk.2024.68.4.215&rft.externalDocID=4010069822819
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0377-9556&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0377-9556&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0377-9556&client=summon